JAMA Medical News

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content: The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (video) A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (audio)

The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid; What to Know About Monkeypox; UN Reports New Insights on Link Between Climate Change and Human Health. Related Content: The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid What to Know About Monkeypox UN Reports New Insights on Link Between Climate Change and Human Health

JAMA Medical News Senior Staff Writer Melissa Suran, PhD, MSJ, speaks with Sonali Smith, MD, about new research and timely topics from the recent annual meeting of the American Society of Clinical Oncology (ASCO). Dr Smith, who chaired the conference's Scientific Program Committee, is also chief of the hematology and oncology section at the University of Chicago Medicine. Related Content: Highlights From the 2022 Annual Meeting of the American Society of Clinical Oncology—Disparities in Clinical Trials, Mitigating Clinician Burnout, and Combination Treatments for Cancer Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer Cancer Risk and Mortality in Adults With Obesity Who Underwent Bariatric Surgery vs No Surgery

Loren Laine, MD, professor of Medicine (Digestive Diseases); chief, Section of Digestive Diseases, Internal Medicine; medical chief, Digestive Health, Yale New Haven Health, discusses the pandemic-related decline in colorectal cancer screening, racial and ethnic disparities in cancer care and survival, and other research highlights from the recent Digestive Disease Week meeting. Related Content: Highlights From Digestive Disease Week—Pandemic-Related Decline in Colorectal Cancer Screening, Lack of Association Between Proton Pump Inhibitors and Dementia, and More

JAMA Senior Editor Kristin L. Walter, MD, MS, speaks with Andrew J. Halayko, PhD, ATSF, MSc, BSc, about some important research studies and keynote addresses presented at the American Thoracic Society (ATS) International Conference in May 2022. Dr Halayko is professor of physiology and internal medicine at the University of Manitoba in Canada and this year's ATS conference chair. Related Article(s): American Thoracic Society 2022 Conference Highlights

What a Post–Roe v Wade US Might Look Like for Physicians; SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus Related Article(s): What a Post–Roe v Wade US Might Look Like for Physicians SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus

Clinical Trials Disrupted During War in Ukraine; The Role of Supervised Consumption Sites for People Who Use Illicit Drugs Related Content: Clinical Trials Disrupted During War in Ukraine The Role of Supervised Consumption Sites for People Who Use Illicit Drugs

Preventive cardiologist and conference cochair Pamela Morris, MD, discusses new heart failure management guidelines and important clinical trial results presented at the American College of Cardiology's 2022 Scientific Sessions. Related Content: Highlights From the American College of Cardiology's Scientific Sessions—New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy Short Interfering RNA Targeting Lp(a) Production in Individuals With Elevated Plasma Lp(a) Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis The Potential Clinical Benefit of Lowering Lipoprotein(a)

Physicians in Ukraine—Caring for Patients in the Middle of a War; The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks; How Cancer Will Affect the US in 2022 Related Content: Physicians in Ukraine: Caring for Patients in the Middle of a War The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks How Cancer Will Affect the US in 2022

Russian attacks on Ukraine have created a humanitarian crisis and made the treatment of patients exponentially more difficult. Two Ukrainian doctors, Oleksandra Shchebet and Anastasiia Barzylovych, share their experiences as they practice medicine in a dangerous wartime environment. Recorded March 9, 2022. Related Content: Physicians in Ukraine: Caring for Patients in the Middle of a War